Biosecure Act would prohibit American companies receiving federal grant money from working with some Chinese groups
Ochre Bio partnering with Germany’s Boehringer Ingelheim on treatments that will harness the organ’s capacity to regenerate
WuXi AppTec and WuXi Biologics under threat from proposed national security legislation
It aims to exploit its extraordinary cache of genetic data but changing corporate DNA is hard
Aardvark Therapeutics’ drug has been shown in trials to suppress cravings in patients with rare genetic form of obesity
Danish group seeks to branch out from diabetes and weight loss drugs with Cardior acquisition
Madrigal is the first to win approval for a treatment for a liver disease that affects one in 20
Advocate general of bloc’s top court says decision against world’s biggest gene sequencing group should be annulled
Funding needed to drive innovation and make therapies available to all, says co-discoverer Jennifer Doudna
Acquisition gives pharmaceutical group mid-stage asset to challenge Novartis in new form of cancer care
GHO Capital has put contract research group FairJourney Biologics up for sale
Baseimmune aims to predict future pathogen mutations to create jabs that will be effective for longer
Drug developers raised $6bn in January, helped by a rebound in merger activity
Boston and Geneva-based enterprise believes new technology will transform dermatology
Sovereign wealth funds Temasek and Mubadala in talks to fund biotech groups harnessing mind-altering substances
Start-ups say new technology could help end animal testing by pharma companies
Danish biotech group Zealand Pharma is developing an alternative obesity treatment to compete with big rivals
‘Molecular factories’ boost field of synthetic biology, raising hopes of developing drugs and other products
Expanded genetic profiling could lead to breakthroughs in diagnosis and therapy for common tumours, landmark global study finds
Oxford university spinout working on polygenic risk scores to help predict disease
Argenx is one of the bloc’s largest biotech companies but its shareholder base is dominated by US specialist investors
Danish manufacturer of Wegovy invests in two start-ups as part of efforts to stay ahead in major new market
Lender invests in venture fund 4Bio Capital as it says UK sector has ‘significant untapped potential’
Sector benefits from shifts in interest rate expectations after 50% fall
Wuxi Biologics is likely to miss its original sales target for the year by about $400mn
